These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1325102)

  • 1. Heterogeneity of a herpes simplex virus clinical isolate exhibiting resistance to acyclovir and foscarnet.
    Pelosi E; Hicks KA; Sacks SL; Coen DM
    Adv Exp Med Biol; 1992; 312():151-8. PubMed ID: 1325102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
    Schmit I; Boivin G
    J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome.
    Birch CJ; Tachedjian G; Doherty RR; Hayes K; Gust ID
    J Infect Dis; 1990 Sep; 162(3):731-4. PubMed ID: 2167340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.
    Chatis PA; Miller CH; Schrager LE; Crumpacker CS
    N Engl J Med; 1989 Feb; 320(5):297-300. PubMed ID: 2536137
    [No Abstract]   [Full Text] [Related]  

  • 5. Mucocutaneous dissemination of acyclovir-resistant herpes simplex virus in a patient with AIDS.
    Marks GL; Nolan PE; Erlich KS; Ellis MN
    Rev Infect Dis; 1989; 11(3):474-6. PubMed ID: 2546244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acyclovir-resistant herpes simplex virus infections in immunocompromised patients].
    Jansen CL; Maris-Tegeler WG; Wertheim-van Dillen PM; Frissen PH; Weiland HT; van der Noordaa J
    Ned Tijdschr Geneeskd; 1992 Feb; 136(6):280-4. PubMed ID: 1311058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acyclovir-resistant herpes simplex virus causing pneumonia after marrow transplantation.
    Ljungman P; Ellis MN; Hackman RC; Shepp DH; Meyers JD
    J Infect Dis; 1990 Jul; 162(1):244-8. PubMed ID: 2162368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity?
    Sacks SL; Wanklin RJ; Reece DE; Hicks KA; Tyler KL; Coen DM
    Ann Intern Med; 1989 Dec; 111(11):893-9. PubMed ID: 2554768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Resistance of herpes simplex viruses to antiviral drugs].
    Scieux C; Bianchi A
    Pathol Biol (Paris); 1993 Feb; 41(2):172-7. PubMed ID: 8392160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients: preliminary data.
    Safrin S; Assaykeen T; Follansbee S; Mills J
    J Infect Dis; 1990 Jun; 161(6):1078-84. PubMed ID: 2161035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of progressive acyclovir-resistant herpes simplex virus using intravenous foscarnet in a patient with the acquired immunodeficiency syndrome.
    Sall RK; Kauffman CL; Levy CS
    Arch Dermatol; 1989 Nov; 125(11):1548-50. PubMed ID: 2554819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A point mutation within a distinct conserved region of the herpes simplex virus DNA polymerase gene confers drug resistance.
    Hwang CB; Ruffner KL; Coen DM
    J Virol; 1992 Mar; 66(3):1774-6. PubMed ID: 1310779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-resistant herpes simplex virus in vitro and after acyclovir treatment in an immunocompromised patient.
    Schnipper LE; Crumpacker CS; Marlowe SI; Kowalsky P; Hershey BJ; Levin MJ
    Am J Med; 1982 Jul; 73(1A):387-92. PubMed ID: 6285729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative methods for detection of thymidine kinase-deficient herpes simplex virus type 1 strains.
    Harmenberg J; Sundqvist VA; Gadler H; Levén B; Brännström G; Wahren B
    Antimicrob Agents Chemother; 1986 Oct; 30(4):570-3. PubMed ID: 3024561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited efficacy of inhibitors of herpes simplex virus DNA synthesis in murine models of recrudescent disease.
    Kristofferson A; Ericson AC; Sohl-Akerlund A; Datema R
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1157-66. PubMed ID: 2838569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of HSV clinical isolates to foscarnet and in vitro dual combination of foscarnet and acyclovir.
    Al-Samarai A; Kinghorn G; Potter C
    Chemioterapia; 1987 Jun; 6(2 Suppl):665-6. PubMed ID: 2855616
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of acyclovir-resistant herpes simplex virus early during the treatment of herpes neonatorum.
    Levin MJ; Weinberg A; Leary JJ; Sarisky RT
    Pediatr Infect Dis J; 2001 Nov; 20(11):1094-7. PubMed ID: 11734722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes simplex type 1 defective interfering particles do not affect the antiviral activity of acyclovir, foscarnet and adenine arabinoside.
    Harmenberg JG; Svensson LT
    Acta Virol; 1988 Mar; 32(2):153-5. PubMed ID: 2899962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA polymerase activities.
    Larder BA; Darby G
    Virology; 1985 Oct; 146(2):262-71. PubMed ID: 2996220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular herpes simplex virus infections: reduced sensitivity to acyclovir in primary disease.
    Charles SJ; Gray JJ
    Br J Ophthalmol; 1990 May; 74(5):286-8. PubMed ID: 2162190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.